Triazolam is a pharmaceutical raw material used as an active pharmaceutical ingredient in the manufacturing of sedative-hypnotic medications. It has a complex ring-containing structure and is associated with developmental toxicity according to government labeling requirements.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 28911-01-5
Alprazolam
active pharmaceutical ingredient
Ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate
impurity standard for dabigatran etexilate
Delorazepam
active pharmaceutical ingredient
Apalutamide Di-(2-fluoro-N-methylbenzamide)
active pharmaceutical ingredient impurity
Canertinib dihydrochloride
active pharmaceutical ingredient
Alpha-Hydroxytriazolam
triazolobenzodiazepine metabolite
8-Chloro-6-(2-chlorophenyl)-1-ethenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
active pharmaceutical ingredient
4-Hydroxytriazolam
n.a
8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
JOFWLTCLBGQGBO-UHFFFAOYSA-N
CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl